Latest Research

Microfluidic gastrointestinal tissue-mimetic microenvironments for long-term organoid culture

Abstract

“Matrigel, a mouse tumor extracellular matrix protein mixture, is an indispensable component of most organoid tissue culture. However, it has limited the utility of organoids for drug development and regenerative medicine due to its tumor-derived origin, batch-to-batch variation, high cost, and safety issues. Here, we demonstrate that gastrointestinal tissue-derived extracellular matrix hydrogels are suitable substitutes for Matrigel in gastrointestinal organoid culture. We found that the development and function of gastric or intestinal organoids grown in tissue extracellular matrix hydrogels are comparable or often superior to those in Matrigel. In addition, gastrointestinal extracellular matrix hydrogels enabled long-term subculture and transplantation of organoids by providing gastrointestinal tissue-mimetic microenvironments. Tissue-specific and age-related extracellular matrix profiles that affect organoid development were also elucidated through proteomic analysis. Together, our results suggest that extracellular matrix hydrogels derived from decellularized gastrointestinal tissues are effective alternatives to the current gold standard, Matrigel, and produce organoids suitable for gastrointestinal disease modeling, drug development, and tissue regeneration.

Microfluidic system for dynamic culture and mass production of GI organoids in ECM hydrogels. Schematic illustration of (a) chip design and (b) the working principle of the microfluidic system for dynamic culture using a rocker. Mass production of (c) gastric and (d) intestinal organoids in GI tissue-derived ECM hydrogels using the microfluidic system. Gastric and intestinal organoids were observed at day 5 and day 6 in the culture, respectively (scale bars = 1 mm). Representative images from three independent experiments are shown in (c) and (d). Reproduced under Creative Commons Attribution 4.0 International License from Kim, S., Min, S., Choi, Y.S. et al. Tissue extracellular matrix hydrogels as alternatives to Matrigel for culturing gastrointestinal organoids. Nat Commun 13, 1692 (2022).


Figures and the abstract are reproduced from Kim, S., Min, S., Choi, Y.S. et al. Tissue extracellular matrix hydrogels as alternatives to Matrigel for culturing gastrointestinal organoids. Nat Commun 13, 1692 (2022). https://doi.org/10.1038/s41467-022-29279-4 under Creative Commons Attribution 4.0 International License.


Read the original article:
Tissue extracellular matrix hydrogels as alternatives to Matrigel for culturing gastrointestinal organoidsPrebiotics and Postbiotics Synergistic Delivery Microcapsules from Microfluidics for Treating Colitis

Pouriya Bayat

Published by
Pouriya Bayat

Recent Posts

A Gut-Liver-on-a-Chip for Studying Drug Absorption, Metabolism, and Interactions

Orally administered drugs encounter several biological barriers before reaching systemic circulation. They must cross the…

September 21, 2026

Label-Free Microfluidic Blood Processing for Platelet and Leukocyte Analysis

Platelets and leukocytes are important participants in thrombosis, inflammation, and immune responses, while interactions between…

September 11, 2026

Mapping Geometry-Dependent Biocementation in Microfluidic Pore Networks

Microbially induced calcium carbonate precipitation (MICP) uses microorganisms to generate CaCO3 within porous materials, helping…

August 31, 2026

How Microfluidic Flow Shapes Root Growth in <em>Medicago sativa</em>

Plant roots continuously respond to the physical and chemical conditions around them, yet the effects…

August 19, 2026

Multiphasic Droplet Microfluidics for Controlled Bacteria and Mammalian Cell Co-Culture

Studying interactions between bacteria and mammalian cells is important for understanding the microbiome, infection, inflammation,…

August 3, 2026

Handheld Microfluidic Platform for Rapid Thrombin and SARS-CoV-2 Spike Protein Detection

Rapid detection of thrombin and SARS-CoV-2 spike protein is useful for very different clinical needs,…

July 20, 2026